Zobrazeno 1 - 10
of 14
pro vyhledávání: '"F Palamidas"'
Autor:
Foteini Karakontaki, Sofia-Antiopi Gennimata, Anastasios F. Palamidas, Theocharis Anagnostakos, Epaminondas N. Kosmas, Anastasios Stalikas, Charalambos Papageorgiou, Nikolaos G. Koulouris
Publikováno v:
Pulmonary Medicine, Vol 2013 (2013)
Background. Cognitive deterioration may impair COPD patient’s ability to perform tasks like driving vehicles. We investigated: (a) whether subclinical neuropsychological deficits occur in stable COPD patients with mild hypoxemia (PaO2 > 55 mmHg), a
Externí odkaz:
https://doaj.org/article/bda7683928ef4fbd97bd5e5e1cf73151
Publikováno v:
Pulmonary Medicine, Vol 2012 (2012)
Patients with severe COPD often exhale along the same flow-volume curve during quite breathing as during forced expiratory vital capacity manoeuvre, and this has been taken as indicating expiratory flow limitation at rest (EFLT). Therefore, EFLT, nam
Externí odkaz:
https://doaj.org/article/b351d5c7cfeb41f495abe11f2bec070e
Publikováno v:
Respiration. 92:127-130
Endobronchial ultrasound has been one of the success stories of the last decade, and the utility of the procedure continues to expand. Originally, it was developed for the staging and diagnosis of lung cancer, but its use rapidly expanded to other ma
Publikováno v:
The Journal of cardiovascular surgery. 44(6)
A 29-year-old male with known von Recklinghausen's disease is presented. The main symptom of the patient was paroxysmal episodes of pain and numbness in the right upper hand for the last 10 years. Cervical and mediastial magnetic resonance imaging (M
Autor:
C, Christodolou, N, Pavlidis, E, Samantas, G, Fountzilas, G, Kouvatseas, K, Pagdatoglou, F, Palamidas, C, Nikolaidis, M, Angelidou, H P, Kalofonos, P, Kosmidis, D V, Skarlos
Publikováno v:
Anticancer research. 22(6B)
Prognostic factors among Greek patients with SCLC were evaluated.Data from 516 patients with SCLC treated by the Hellenic Cooperative Oncology Group were analyzed. Multivariate analysis was performed.Complete response (CR) was achieved in 26.8% and p
Autor:
C. Kourousis, A Adravanis, F Apostolaki, K Kandilis, Sophia Agelaki, V. Georgoulias, F Apostolopoulou, E. Papadakis, Nikos Androulakis, F Palamidas, E. Sarra, Th Gianakakis, A. Agelidou, E. Bania, V Tziani, Ageliki Rapti
Publikováno v:
Lung Cancer. 21:S36-S37
Autor:
N. Pavlidis, P. Kosmidis, M. Milonakis, E. Kosmas, M. Agelidou, F. Palamidas, G. Klouvas, A. Panoussaki, Epaminontas Samantas, E. Papadakis, E. Boleli, G. Foutzilas, D.V. Skarios, T h Vardoulakis, N. Kiamouris
Publikováno v:
European Journal of Cancer. 31:S22-S23
Between 2/88 and 5/91, 143 patients (pts) with SCLC (82 extensive and 61 limited disease) were randomized to receive Cisplatin and Etoposide (PE) or Carboplatin and Etoposide (CE). Responders, received concurrently with the 3rd cycle of chemotherapy
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.